(Q42150777)

17 October 2017

title

High serum levels of TNF-alpha after its administration for isolation perfusion of the limb (English)

1 reference

17 October 2017

High serum levels of TNF-α after its administration for isolation perfusion of the limb (English)

1 reference

https://api.crossref.org/works/10.1016/1043-4666(92)90024-L

regional perfusion chemotherapy

27 November 2023

main subject

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1292642

27 November 2023

1 reference

https://api.crossref.org/works/10.1016/1043-4666(92)90024-L

27 November 2023

1 reference

https://api.crossref.org/works/10.1016/1043-4666(92)90024-L

27 November 2023

author name string

J. Gérain

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1292642

27 November 2023

D. Liénard

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1292642

27 November 2023

P. Ewalenko

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1292642

27 November 2023

F. J. Lejeune

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1292642

27 November 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1292642

27 November 2023

publication date

1 November 1992

1 reference

full work available at URL

17 October 2017

https://api.elsevier.com/content/article/PII:104346669290024L?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/1043-4666(92)90024-L

https://api.elsevier.com/content/article/PII:104346669290024L?httpAccept=text/plain

27 November 2023

1 reference

https://api.crossref.org/works/10.1016/1043-4666(92)90024-L

27 November 2023

1 reference

17 October 2017

volume

4

1 reference

17 October 2017

issue

6

1 reference

17 October 2017

page(s)

585-591

1 reference

A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes.

17 October 2017

cites work

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1016/0022-1759(86)90322-4

An endotoxin-induced serum factor that causes necrosis of tumors

1

1 reference

https://api.crossref.org/works/10.1016/1043-4666(92)90024-L

Effect of tumour necrosis factor on cultured human melanoma cells

27 November 2023

2

1 reference

https://api.crossref.org/works/10.1016/1043-4666(92)90024-L

Cachectin/tumor necrosis factor exerts endocrine, paracrine, and autocrine control of inflammatory responses

27 November 2023

4

1 reference

https://api.crossref.org/works/10.1016/1043-4666(92)90024-L

Shock and tissue injury induced by recombinant human cachectin

27 November 2023

5

1 reference

https://api.crossref.org/works/10.1016/1043-4666(92)90024-L

Role of tumour necrosis factor in the tumour-necrotizing activity of agents with diverging toxicity

27 November 2023

6

1 reference

https://api.crossref.org/works/10.1016/1043-4666(92)90024-L

Increased peripheral blood leukocyte cytotoxic activity in cancer patients during the continuous intravenous administration of recombinant human tumor necrosis factor

27 November 2023

7

1 reference

https://api.crossref.org/works/10.1016/1043-4666(92)90024-L

Resistance of tumor cells to tumor necrosis factor

27 November 2023

8

1 reference

https://api.crossref.org/works/10.1016/1043-4666(92)90024-L

Combined effects of tumor necrosis factor alpha and radiation in the treatment of renal cell carcinoma grown as radia spheroids

27 November 2023

9

1 reference

https://api.crossref.org/works/10.1016/1043-4666(92)90024-L

Evaluation of cytokine levels in whole cell cultures of patients with gynaecological tumors as diagnostic parameters

27 November 2023

11

1 reference

https://api.crossref.org/works/10.1016/1043-4666(92)90024-L

A phase I trial of intravenously-administered recombinant tumor necrosis factor-alpha in cancer patients

27 November 2023

12

1 reference

https://api.crossref.org/works/10.1016/1043-4666(92)90024-L

A phase I clinical trial of recombinant human tumor necrosis factor

27 November 2023

13

1 reference

https://api.crossref.org/works/10.1016/1043-4666(92)90024-L

Recombinant tumour necrosis factor alpha administered subcutaneously or intramuscularly for treatment of advanced malignant disease: a phase I trial

27 November 2023

14

1 reference

https://api.crossref.org/works/10.1016/1043-4666(92)90024-L

Effect of intraperitoneal recombinant human tumour necrosis factor alpha on malignant ascites

27 November 2023

15

1 reference

https://api.crossref.org/works/10.1016/1043-4666(92)90024-L

High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma

27 November 2023

17

1 reference

https://api.crossref.org/works/10.1016/1043-4666(92)90024-L

Phase I trial of recombinant human gamma-interferon and recombinant human tumor necrosis factor in patients with advanced gastrointestinal cancer

27 November 2023

24

1 reference

https://api.crossref.org/works/10.1016/1043-4666(92)90024-L

Intralesional tumour necrosis factor combined with interferon gamma in metastatic melanoma

27 November 2023

25

1 reference

https://api.crossref.org/works/10.1016/1043-4666(92)90024-L

Cathepsin-G and leukocyte elastase inactivate human tumor necrosis factor and lymphotoxin

27 November 2023

28

1 reference

https://api.crossref.org/works/10.1016/1043-4666(92)90024-L

Prognostic Values of Tumor Necrosis Factor/Cachectin, Interleukin-l, Interferon- , and Interferon- in the Serum of Patients with Septic Shock

27 November 2023

29

1 reference

https://api.crossref.org/works/10.1016/1043-4666(92)90024-L

Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia

27 November 2023

30

1 reference

https://api.crossref.org/works/10.1016/1043-4666(92)90024-L

Divergent efficacy of antibody to tumor necrosis factor-alpha in intravascular and peritonitis models of sepsis

27 November 2023

31

1 reference

https://api.crossref.org/works/10.1016/1043-4666(92)90024-L

Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease

27 November 2023

33

1 reference

https://api.crossref.org/works/10.1016/1043-4666(92)90024-L

Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits

27 November 2023

35

1 reference

https://api.crossref.org/works/10.1016/1043-4666(92)90024-L

Circulating interleukin 6 during a continuous infusion of tumor necrosis factor and interferon gamma

27 November 2023

36

1 reference

https://api.crossref.org/works/10.1016/1043-4666(92)90024-L

High circulating levels of interleukin-6 in patients with septic shock: Evolution during sepsis, prognostic value, and interplay with other cytokines

27 November 2023

37

1 reference

https://api.crossref.org/works/10.1016/1043-4666(92)90024-L

Experimental elimination of tumor necrosis factor in low-dose endotoxin models has variable effects on survival

27 November 2023

38

1 reference

https://api.crossref.org/works/10.1016/1043-4666(92)90024-L

27 November 2023

Identifiers

1 reference

17 October 2017

1 reference